Back to search results

Testing the AMPERE EMA App for Suicidal Ideation

This study is testing a smartphone app called AMPERE EMA for young adults aged 16-30 who are experiencing suicidal thoughts or have a history of self-harm. The goal is to see if this app is a helpful and easy-to-use tool for managing suicide risk in primary care settings. You would use the AMPERE EMA app for two months. Researchers will measure how acceptable and usable the app is, and how satisfied you are with it, after two months of use. This study aims to improve how healthcare providers support young adults at risk of suicide.

Study design
This is an interventional study planning to enroll 50 participants. It is not specified if it is randomized or blinded.
What's involved
You would download and use the AMPERE EMA prototype app for a total of two months.
Compensation
Not stated in the trial record.
Follow-up
Your feedback on the app's acceptability, usability, and your satisfaction will be measured at two months after starting to use the app.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06704958

Augmented Momentary Personal Ecological Risk Evaluation

Terminated
NAAges 16–30InterventionalHealth services
University of Washington
~1 participants
Updated 2026-08-21 on ClinicalTrials.gov
What's tested:AMPERE EMA app

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability of Intervention Scale (AIM)
Measured over 2 month post-initiation of AMPERE EMA use
+2 more outcomes measured

Conditions

Suicidal Ideation
Self Harm

Explore related trials

Self-injurious behaviorSuicidal Ideation

Where it's being run

1 sites across 1 states
Washington1

Study leadership

  • Ian M Bennett, MD, PhD · PRINCIPAL_INVESTIGATOR · University of Washington

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Young adults (age 16-30 years)
Receiving care at University of Washington Primary Care for suicidal ideation as determined by Electronic Health Record problem list or PHQ-9 suicide risk item \>0 in previous year and/or recent (past year) history of suicide attempt and/or active suicidal ideation.
Ability to consent to participate

Exclusion

Age \<16 or \>30,
Non-English speaking
No smart phone access
Any clinical medical/psychiatric condition, severity of that condition, or life situation that would compromise safe and voluntary study participation.

What this trial measures

  • Acceptability of Intervention Scale (AIM)2 month post-initiation of AMPERE EMA use

    This is a four-item measure of intervention acceptability, where each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. Total mean scores range from 1 - 5, with higher scores indicating higher acceptability. Participants will complete this measure after 4 weeks of using the mobile mental health app to which they are randomized.

  • System Usability Scale (SUS)2 month post-initiation of AMPERE EMA use

    This is a 10 item measure of system usability with 5 response options. SUS score can range from 0 to 100 with a higher score indicating high usability.

  • Client Satisfaction Questionnaire (CSQ)2 month post-initiation of AMPERE EMA use

    This is a 3 item measure to assess consumer satisfaction with health and human services